Brokerages expect Safeguard Scientifics, Inc (NYSE:SFE) to report $0.80 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Safeguard Scientifics’ earnings. Safeguard Scientifics reported earnings per share of ($0.30) during the same quarter last year, which would suggest a positive year over year growth rate of 366.7%. The firm is scheduled to announce its next earnings report on Thursday, April 25th.
According to Zacks, analysts expect that Safeguard Scientifics will report full year earnings of ($1.40) per share for the current year. For the next year, analysts expect that the firm will post earnings of ($1.99) per share. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side research analysts that follow Safeguard Scientifics.
Safeguard Scientifics (NYSE:SFE) last released its quarterly earnings results on Thursday, February 28th. The asset manager reported ($0.81) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.93) by $0.12.
NYSE SFE traded down $0.04 during trading hours on Friday, reaching $10.85. 83,535 shares of the stock traded hands, compared to its average volume of 91,427. Safeguard Scientifics has a 1 year low of $7.98 and a 1 year high of $13.95. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.64. The company has a market capitalization of $224.90 million, a price-to-earnings ratio of -14.28 and a beta of 1.04.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SFE. Northern Trust Corp raised its position in Safeguard Scientifics by 4.8% during the second quarter. Northern Trust Corp now owns 257,886 shares of the asset manager’s stock valued at $3,301,000 after purchasing an additional 11,705 shares in the last quarter. JPMorgan Chase & Co. raised its position in Safeguard Scientifics by 117.2% during the third quarter. JPMorgan Chase & Co. now owns 116,771 shares of the asset manager’s stock valued at $1,092,000 after purchasing an additional 62,998 shares in the last quarter. Prudential Financial Inc. increased its holdings in shares of Safeguard Scientifics by 23.9% in the third quarter. Prudential Financial Inc. now owns 53,361 shares of the asset manager’s stock worth $499,000 after buying an additional 10,300 shares during the period. Janus Henderson Group PLC increased its holdings in shares of Safeguard Scientifics by 11.8% in the third quarter. Janus Henderson Group PLC now owns 474,347 shares of the asset manager’s stock worth $4,423,000 after buying an additional 49,960 shares during the period. Finally, Prescott Group Capital Management L.L.C. increased its holdings in shares of Safeguard Scientifics by 313.0% in the third quarter. Prescott Group Capital Management L.L.C. now owns 453,652 shares of the asset manager’s stock worth $4,242,000 after buying an additional 343,805 shares during the period. Institutional investors and hedge funds own 69.17% of the company’s stock.
About Safeguard Scientifics
Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.
Featured Article: Why do companies issue convertible shares?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.